Related references
Note: Only part of the references are listed.Interleukin (IL)-19, IL-20 and IL-24 are produced by and act on keratinocytes and are distinct from classical ILs
Stefanie Kunz et al.
EXPERIMENTAL DERMATOLOGY (2006)
Skin retinoid concentrations are modulated by CYP26AI expression restricted to basal keratinocytes in normal human skin and differentiated 3D skin models
Ruth Heise et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Adipose tissue as a novel target for in vivo gene transfer by adeno-associated viral vectors
Hiroaki Mizukami et al.
HUMAN GENE THERAPY (2006)
Fibroblasts show more potential as target cells than keratinocytes in COL7A1 gene therapy of dystrophic epidermolysis bullosa
Maki Goto et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Progress and prospects of skin gene therapy: a ten year history
UR Hengge
CLINICS IN DERMATOLOGY (2005)
Human growth hormone and insulin-like growth factor-I inhibit erythropoietin secretion from the kidneys of adult rats
M Sohmiya et al.
JOURNAL OF ENDOCRINOLOGY (2005)
Perspectives for gene therapy in renal diseases
E Imai et al.
INTERNAL MEDICINE (2004)
Adenovirus-mediated erythropoietin production by airway epithelia is enhanced by apical localization of the coxsackie-adenovirus receptor in vivo
B Davis et al.
MOLECULAR THERAPY (2004)
Lentivectors for regulated and reversible cutaneous gene delivery
Z Siprashvili et al.
MOLECULAR THERAPY (2004)
Treatment of erythropoietin-induced pure red cell aplasia:: a retrospective study
D Verhelst et al.
LANCET (2004)
A neovascularized organoid derived from retrovirally engineered bone marrow stroma leads to prolonged in vivo systemic delivery of erythropoietin in nonmyeloablated, immunocompetent mice
N Eliopoulos et al.
GENE THERAPY (2003)
Dose finding with retroviral vectors: correlation of retroviral vector copy numbers in single cells with gene transfer efficiency in a cell population
OS Kustikova et al.
BLOOD (2003)
Red blood cells
SP Klinken
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2002)
Long-term reversal of chronic anemia using a hypoxia-regulated erythropoietin gene therapy
K Binley et al.
BLOOD (2002)
Topical colchicine selection of keratinocytes transduced with the multidrug resistance gene (MDR1) can sustain and enhance transgene expression in vivo
W Pfützner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Comparison of epidermal keratinocytes and dermal fibroblasts as potential target cells for somatic gene therapy of phenylketonuria
R Christensen et al.
MOLECULAR GENETICS AND METABOLISM (2002)
Hypoxia - A key regulatory factor in tumour growth
AL Harris
NATURE REVIEWS CANCER (2002)
Skin genetically engineered as a bioreactor or a 'metabolic sink'
R Christensen et al.
CELLS TISSUES ORGANS (2002)
Lentivirus administration to rat muscle provides efficient sustained expression of erythropoietin
J Seppen et al.
BLOOD (2001)
Sustainable systemic delivery via a single injection of lentivirus into human skin tissue
SC Baek et al.
HUMAN GENE THERAPY (2001)
Cutaneous gene therapy - an update
R Christensen et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2001)
Advances in skin gene therapy
W Pfutzner et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2000)
Adeno-associated virus expresses transgenes in hair follicles and epidermis
UR Hengge et al.
MOLECULAR THERAPY (2000)
Share Paper
